IHRC, Inc., Atlanta, Georgia; Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia; Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee.
Am J Prev Med. 2022 Feb;62(2):285-298. doi: 10.1016/j.amepre.2021.06.025. Epub 2021 Oct 20.
Self-measured blood pressure monitoring with support is an evidence-based intervention that helps patients control their blood pressure. This systematic economic review describes how certain intervention aspects contribute to effectiveness, intervention cost, and intervention cost per unit of the effectiveness of self-measured blood pressure monitoring with support.
Papers published between data inception and March 2021 were identified from a database search and manual searches. Papers were included if they focused on self-measured blood pressure monitoring with support and reported blood pressure change and intervention cost. Papers focused on preeclampsia, kidney disease, or drug efficacy were excluded. Quality of estimates was assessed for effectiveness, cost, and cost per unit of effectiveness. Patient characteristics and intervention features were analyzed in 2021 to determine how they impacted effectiveness, intervention cost, and intervention cost per unit of effectiveness.
A total of 22 studies were included in this review from papers identified in the search. Type of support was not associated with differences in cost and cost per unit of effectiveness. Lower cost and cost per unit of effectiveness were achieved with simple technologies such as interactive phone systems, smartphones, and websites and where providers interacted with patients only as needed.
Some of the included studies provided only limited information on key outcomes of interest to this review. However, the strength of this review is the systematic collection and synthesis of evidence that revealed the associations between the characteristics of implemented interventions and their patients and the interventions' effectiveness and cost, a useful contribution to the fields of both research and implementation.
自我监测血压并获得支持是一种基于证据的干预措施，有助于患者控制血压。本系统经济评价描述了支持下的自我监测血压干预的某些干预方面如何有助于提高干预效果、降低干预成本，并提高干预成本效益比。
从数据库检索和手动检索中确定了自数据开始至 2021 年 3 月发表的文献。如果研究重点是支持下的自我监测血压，并报告血压变化和干预成本，则纳入研究。排除了关注子痫前期、肾脏疾病或药物疗效的研究。对有效性、成本和成本效益比的估计质量进行了评估。对患者特征和干预特征进行了分析，以确定它们如何影响有效性、干预成本和成本效益比。
从搜索中确定的文献中共有 22 项研究纳入本综述。支持的类型与成本和成本效益比单位没有差异。采用交互式电话系统、智能手机和网站等简单技术，以及仅在需要时与患者互动的方式，可以降低成本和成本效益比单位。
部分纳入研究仅提供了本综述中感兴趣的关键结果的有限信息。然而，本综述的优势在于系统地收集和综合证据，揭示了干预措施的特点与其患者以及干预措施的有效性和成本之间的关联，这对研究和实施领域都是一个有用的贡献。
